Notification Requirements for Schedule 2, Least-Developed Countries
Least-developed countries, as identified on Schedule
2 to Canada's  Patent Act, planning
to use Canada's Access to Medicines Regime are required to notify
For instructions on how to provide notice, see Notifying
the World Trade Organization or
Notifying the Government of Canada.
Countries must disclose the following information to the appropriate authority when planning to use the
Regime:
- The name and quantity of the drug or medical device needed; and
- A declaration that the product is not patented in the importing country; or
- If the product is patented in the importing country, a declaration that the country will or has issued
a compulsory licence authorizing it to use the
product.
Least-developed countries that are not members of the WTO
are also required to declare that they will adopt
measures to prevent diversion of the products to unintended markets.
For a graphic illustration of the notification process, see the process map for Schedule 2 countries.
|
